Clinical trial Recruiting at 1 site Observational Ages 18 and up

Comparing SPECT-CT and MRI for diagnosing foot and ankle osteoarthritis

Official title: SPECT-CT Versus MRI for the Diagnosis of Symptomatic Osteoarthritis in the Ankle, Hind- and Midfoot.

Run by Martini Hospital Groningen · NCT05912153 · Data updated 2026-11-12

This study is testing whether SPECT-CT or MRI is better at diagnosing osteoarthritis in the foot and ankle for patients who have symptoms.

More Osteoarthritis trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment132 (estimated)
SponsorMartini Hospital Groningen
Academic / other
Locations1 site (Groningen)
StatusRecruiting
StartedJuly 4, 2023
Main results expectedDecember 1, 2026
Study endsDecember 2027
Registry record updatedFebruary 27, 2026
Trial IDNCT05912153 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with suspected symptomatic osteoarthritis of the ankle, hindfoot, or midfoot and a pain score of 4 or higher.

Probably not a fit

Patients with contraindications for SPECT-CT or MRI, recent trauma, or isolated forefoot pathology may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the diagnostic performance of SPECT-CT and MRI in patients with symptomatic osteoarthritis of the ankle, hindfoot, and midfoot. It involves a prospective cohort design where patients aged 18 and older, referred to the Martini Hospital Groningen, will undergo both imaging techniques as part of their standard workup. The study will assess parameters such as sensitivity, specificity, and predictive values to determine which imaging modality provides better diagnostic accuracy. The findings could help standardize diagnostic protocols for osteoarthritis in these areas.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic accuracy for osteoarthritis in the foot and ankle, potentially enhancing treatment plans for patients.

How similar studies have gone: While there have been studies indicating the potential of SPECT-CT in diagnosing osteoarthritis, this study is among the first to prospectively compare SPECT-CT and MRI in this specific context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Suspected symptomatic ankle, hind- or midfoot OA
* Informed consent
* Age ≥ 18 years
* Average NRS ≥4 over the past week.

Exclusion Criteria:

* Contraindication for surgery
* Contraindication for SPECT-CT or MRI
* Contraindication for intra-articular injections
* Isolated forefoot pathology
* Fracture, ligamentous or tendon injury of the ankle, hind- and/or midfoot trauma within one year before presentation
* History of neurological disease
* History of foot and/or ankle surgery (affected side)
* Inability to read and understand the written information

Where it's running

  • Martini Hospital
    Groningen, Netherlands
    Recruiting

Study contacts

  • Principal investigator: Tom van Raaij, MD/PhD — Martini Ziekenhuis
  • Study coordinator: Arthur van Hasselt, MD
  • Email: a.vanHasselt@mzh.nl
  • Phone: 0031646345384

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.